Data: Philip Morris International; Chart: Axios Visuals
Philip Morris International plans to build a new factory in Colorado to make Zyn nicotine pouches.
Why it matters: The company is enjoying surging sales of the smokeless product.
PMI — which is independent of Philip Morris USA owner Altria — bought Zyn owner Swedish Match for $16 billion in 2022.
Driving the news: The $600 million plant will be constructed in Aurora, Colorado, with plans to hire 500 workers.
How it works: Zyn is designed to be placed between the gum and upper lip for the user to absorb nicotine without swallowing, Axios' April Rubin reported.
The pouches are discrete and don't produce smoke or odors like cigarettes and e-cigarettes.
It doesn't contain tobacco leaf, but the FDA considers it to be part of the tobacco industry.
Yes, but: The company recently temporarily halted online sales after the District of Columbia sent a subpoena requesting information on whether Zyn pouches comply with its ban on the sale of flavored tobacco.
Critics warn that nicotine is addictive and can be a gateway to smoking — but advocates, including PMI, say it's a safer alternative to cigarettes.